Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Joyce Mitsuyoshi"'
Publikováno v:
Transfusion. 41:1225-1233
BACKGROUND: RBCs modified with cyanuric chloride activated methoxy-PEG (CmPEG; 5000 Da) are less immunogenic than untreated RBCs, and their use thus may reduce the risk of alloimmunization in chronically transfused patients. STUDY DESIGN AND METHODS:
Publikováno v:
Infection and Immunity. 69:3031-3040
Previous studies have demonstrated an adjuvant effect for the C3d fragment of complement C3 when coupled to T-dependent protein antigens. In this study, we examined the antibody response to covalent conjugates of C3d and a T-independent antigen, the
Autor:
Joyce Mitsuyoshi, Samuel T. Test
Publikováno v:
Journal of Laboratory and Clinical Medicine. 130:169-182
The aminophospholipids phosphatidylserine (PS) and phosphatidylethanolamine (PE) are exposed on the outer membrane leaflet of deoxygenated and irreversibly sickled erythrocytes and senescent normal cells. PS exposure on erythrocytes results in the ex
Autor:
Samuel T. Test, Joyce Mitsuyoshi
Publikováno v:
Blood. 86:2799-2806
Calcium-loaded red blood cells (RBCs) previously have been shown to have an increased sensitivity to complement-mediated hemolysis and particularly to lysis mediated by the C5b-9 membrane attack complex (MAC) of complement. Because RBCs exposed to 2-
Publikováno v:
Infection and immunity. 73(11)
Conjugation of the complement fragment C3d to both T-cell-dependent (TD) protein and T-cell-independent type 2 (TI-2) polysaccharide antigens enhances the humoral immune response in mice immunized with either type of antigen. However, the ability of
Publikováno v:
Infection and immunity. 73(1)
Complement activation plays a critical role in the immune response to T-cell-dependent and T-cell-independent antigens. However, the effect of conjugation of T-cell-dependent protein carriers to T-cell-independent type 2 antigens on the requirement f
Autor:
Samuel T. Test, Lori Styles, Frans A. Kuypers, Emilee M. Bargoma, Joyce Mitsuyoshi, Sandra Larkin
Publikováno v:
Blood. 105:3384-3385
Previous studies from our institution have shown that serum secretory phospholipase A2 (sPLA2) levels are markedly increased in sickle cell disease (SCD) patients with acute chest syndrome (ACS)[1][1] and that sequential measurements of sPLA2 are use